capecitabine has been researched along with Scleroderma, Localized in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hengge, UR; Marini, A | 1 |
Hwang, SJ; Kim, BS; Kim, HJ; Kim, YJ; Lee, SD; Nam, SH | 1 |
FariƱa, MC; Haro, R; Requena, L; Trindade, F | 1 |
3 other study(ies) available for capecitabine and Scleroderma, Localized
Article | Year |
---|---|
[Hand-foot syndrome with capecitabine therapy].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Esophageal Neoplasms; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Scleroderma, Localized; Syndrome | 2007 |
Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Male; Risk Factors; Scleroderma, Localized | 2007 |
Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine.
Topics: Adenocarcinoma; Administration, Oral; Biopsy, Needle; Capecitabine; Deoxycytidine; Dose-Response Relationship, Drug; Fluorouracil; Follow-Up Studies; Hand Dermatoses; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Scleroderma, Localized; Severity of Illness Index; Sigmoid Neoplasms; Syndrome | 2008 |